Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15981020 | 0.94 | CYP3A4 (0.42) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL10033172 | 0.94 | CYP3A4 (0.42) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL12909396 | 0.89 | CYP3A4 (0.39) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL16383172 | 0.89 | CYP3A4 (0.52) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL14826119 | 0.89 | CYP3A4 (0.67) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL13866485 | 0.89 | CYP3A4 (0.39) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL14039351 | 0.89 | CYP3A4 (0.39) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL34881 | 0.89 | CYP3A4 (0.67) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL20045932 | 0.89 | CYP3A4 (0.39) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL2603375 | 0.89 | CYP3A4 (0.39) | CYP3A4TSHRMAPK1TDP1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11839700-B2 | Bio-electrode composition, bio-electrode, and method for manufacturing a bio-electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-12-12 | — | — | US | disclosed |
| US-20230231104-A1 | PRECURSOR SOLUTION, AND MODIFIED LAYER AND LITHIUM-BASED BATTERY PREPARED BY USING THE SAME | NATIONAL TSING HUA UNIVERSITY (TW) | 2023-07-20 | — | — | US | disclosed |
| US-20230167229-A1 | BLOCKED ISOCYANATE COMPOSITION, HEAT-CURABLE RESIN COMPOSITION, CURED PRODUCT, PRODUCTION METHOD THEREFOR, AMIDATE COMPOUND, AND CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2023-06-01 | — | — | US | disclosed |
| US-20180215876-A1 | STRETCHABLE FILM AND METHOD FOR FORMING THE STRETCHABLE FILM | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-08-02 | — | — | US | disclosed |
| US-20180157174-A1 | NEGATIVE TYPE PHOTOSENSITIVE RESIN COMPOSITION, NEGATIVE TYPE PLANOGRAPHIC PRINTING PLATE PRECURSOR, AND METHOD OF PREPARING PLANOGRAPHIC PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2018-06-07 | — | — | US | disclosed |
| US-20180149975-A1 | NEGATIVE TYPE PHOTOSENSITIVE RESIN COMPOSITION, NEGATIVE TYPE PLANOGRAPHIC PRINTING PLATE PRECURSOR, AND METHOD OF PREPARING PLANOGRAPHIC PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2018-05-31 | — | — | US | disclosed |
| US-20180134860-A1 | STRETCHABLE FILM, METHOD FOR FORMING THE SAME, STRETCHABLE WIRING FILM, AND METHOD FOR MANUFACTURING THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-05-17 | — | — | US | disclosed |
| US-20180118915-A1 | STRETCHABLE FILM, METHOD FOR FORMING THE SAME, STRETCHABLE WIRING FILM, AND METHOD FOR MANUFACTURING THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-05-03 | — | — | US | disclosed |
| US-20170340623-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | ARDELYX, INC. | 2017-11-30 | — | — | US | disclosed |
| US-20170335076-A1 | STRETCHABLE FILM AND METHOD FOR FORMING THE SAME, METHOD FOR MANUFACTURING COATED WIRING SUBSTRATE, AND STRETCHABLE WIRING FILM AND METHOD FOR MANUFACTURING THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-11-23 | — | — | US | disclosed |
| US-20120263670-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | ARDELYX, INC. (US) | 2012-10-18 | — | — | US | disclosed |
| US-20120195915-A1 | IAP BIR domain binding compounds | PHARMASCIENCE INC. (CA) | 2012-08-02 | — | — | US | disclosed |
| US-20120189915-A1 | ELECTRODE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2012-07-26 | — | — | US | disclosed |
| US-20120052445-A1 | IMAGE FORMING MATERIAL, PLANOGRAPHIC PRINTING PLATE PRECURSOR, AND METHOD FOR MANUFACTURING A PLANOGRAPHIC PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2012-03-01 | — | — | US | disclosed |
| US-20110281200-A1 | COMPOUND AND COMPOSITION INCLUDING COMPOUND, WITH FUEL CELL, FUEL CELL ELECTRODE AND FUEL CELL ELECTROLYTE MEMBRANE USING SAME | SNU R&DB FOUNDATION (KR) | 2011-11-17 | — | — | US | disclosed |
| US-20110217656-A1 | POSITIVE-WORKING LITHOGRAPHIC PRINTING PLATE PRECURSOR FOR INFRARED LASER AND PROCESS FOR MAKING LITHOGRAPHIC PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2011-09-08 | — | — | US | disclosed |
| US-20110195338-A1 | HYPER-BRANCHED POLYMER, ELECTRODE AND ELECTROLYTE MEMBRANE INCLUDING THE HYPER-BRANCHED POLYMER, AND FUEL CELL INCLUDING AT LEAST ONE OF THE ELECTRODE AND THE ELECTROLYTE MEMBRANE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-08-11 | — | — | US | disclosed |
| US-20110151338-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | SANYO ELECTRIC CO., LTD. (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110046982-A1 | METHODS AND COMPOSITIONS RELATED TO VIRAL INHIBITION | CLEMSON UNIVERSITY RESEARCH FOUNDATION (CURF) (US) | 2011-02-24 | — | — | US | disclosed |
| US-20110020591-A1 | TREATMENT COMPRISING WATER- AND OIL-REPELLENT AGENT | DAIKIN INDUSSRIES, LTD. (JP) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120263670-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | SLC10A1, SLC10A2, FABP2 | CYP3A4 4058/4885TSHR 688/4885MAPK1 2602/4885 |
| US-20170340623-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | SLC10A1, SLC10A2, FABP3 | CYP3A4 3251/4885TSHR 680/4885MAPK1 2648/4885 |
| US-20120195915-A1 | IAP BIR domain binding compounds | BIRC5, BIRC2, BIRC3 | CYP3A4 4548/4885TSHR 3389/4885MAPK1 890/4885 |
| US-20110046982-A1 | METHODS AND COMPOSITIONS RELATED TO VIRAL INHIBITION | EIF2AK2, NSUN2, NSUN3 | CYP3A4 3223/4885TSHR 4866/4885MAPK1 4477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.